Clinical Observation On The Treatment Of Type ? B Chronic Pelvic Pain Syndrome(qi Stagnation And Blood Stasis Syndrome)based On The Theory Of Collateral Disease

Objective:Under the guidance of the theory of collaterals,Liqi Huoxue Fang was formed and the clinical curative effect of treating IIIB chronic pelvic pain syndrome?qi stagnation and blood stasis syndrome?was observed by observing Liqi Huoxue Fang,which provided a reliable treatment method for clinicians.Methods:Clinically,120 patients with type IIIB chronic pelvic pain syndrome?qi stagnation and blood stasis syndrome?were randomly collected and randomly divided into trial group and control group according to a random number table,60 cases in each group.The experimental group was based on the theory of collaterals Liqi Huoxue Fang,one dose per day,400 ml of water,and served twice a day sooner or later.The control group received QianLieShuTong capsules,3 capsules,3 times a day.Four weeks for a course of treatment.The changes of TCM syndrome score,The National Institutes of Health chronic prostatitis symptom index?NIH-CPSI?,Symptom Frequency Questionaire?SFQ?,Symptom Severity Index?SSI?,and Corp in EPS were observed before and after the treatment.To verify the therapeutic effect of Liqihuoxue Fang on this disease.The intensive research literature analyzes the pathogenesis,diagnosis and treatment of type IIIB chronic pelvic pain syndrome?qi stagnation and blood stasis syndrome?from the perspective of collateral disease theory.Integrate theoretical research with clinical practice to explore the guiding role of collateral disease theory in clinical practice.Results:?1?The patients in the experimental group were 60 cases,5 were detached,and the rest were 55 cases.Seven patients were cured,28 were markedly effective,15 were effective,5 were ineffective,and the total effective rate was 90.91%.The control group included 60 patients,5 patients fell off,and the remaining 55 patients.Two cases were cured,18 cases were markedly effective,20 cases were effective,and 15 cases were ineffective.The total effective rate was 72.73%.The test group was superior to the control group P<0.05?the efficacy comparison P=0.001,the total effective rate comparison P=0.024?.?2?Comparison of two groups of TCM syndrome scores:before treatment,the experimental group was 19.42±2.67,the control group was 19.05±2.88;after treatment,the experimental group was 5.38±4.13,the control group was9.35±5.96;the difference between the experimental group and the control group was14.04±4.82,and the control group was 4.82%.Before treatment,the two groups were compared:P=0.494.There was no significant difference in the data between the two groups,and it was comparable.The comparison of P<0.05?P₁=0.000,P₂=0.000?before and after treatment in the two groups was significantly improved.After treatment,P=0.002 was compared,and the difference was compared with P=0.001before and after treatment,and the test group was better than the control group.?3?Comparison of NIH-CPSI scores between the two groups after treatment:before treatment,the test group was 22.67±3.34,and the control group was 21.96±4.05.After treatment,the experimental group was 6.31±4.57 and the control group was 9.35±5.96.The difference between the experimental group and the control group was 16.36±5.52,while the control group was 12.62±6.47.Before treatment,the two groups were compared:P=0.319.There was no significant difference in the data between the two groups,and it was comparable.The comparison of P<0.05?P₁=0.000,P₂=0.000?before and after treatment in the two groups was significantly improved.After treatment,P=0.003 was compared,and the difference was compared with P=0.001 before and after treatment,and the test group was better than the control group.?4?The symptom frequency?SFQ?of the two groups was compared:before treatment,the experimental group was 16.20±4.15,and the control group was 17.21±4.27.After treatment,the experimental group was 4.56±3.74 and the control group was 8.02±5.79.The difference between the experimental group and the control group was 11.64±5.23,and the control group was 5.23%.Before treatment,the two groups were compared:P=0.208.There was no significant difference in the data between the two groups,and it was comparable.The comparison of P<0.05?P₁=0.000,P₂=0.000?before and after treatment in the two groups was significantly improved.After treatment,P=0.000 was compared,and the difference was compared with P=0.006before and after treatment,and the test group was better than the control group.?5?The two groups were compared with the symptom severity scale?SSI?after treatment:before treatment,the experimental group was 32.87±6.74,while the control group was 32.25±5.19.After treatment,the experimental group was 8.91±6.74 and the control group was 13.55±8.41.The difference between the experimental group and the control group was 23.96±9.38,and the control group was 9.38%.Before treatment,the two groups were compared:P=0.591.There was no significant difference in the data between the two groups,and it was comparable.The comparison of P<0.05?P₁=0.000,P₂=0.000?before and after treatment in the two groups was significantly improved.After treatment,P=0.002 was compared,and the difference was compared with P=0.004 before and after treatment,and the test group was better than the control group.?6?The comparison of corp in EPS between two groups after treatment:before treatment,the experimental group was 32.87±6.74,and the control group was 32.25±5.19.After treatment,the experimental group was 8.91±6.74 and the control group was 13.55±8.41.The difference between the experimental group and the control group was 23.96±9.38,and the control group was 9.38%.Before treatment,the two groups were compared:P=0.791.There was no significant difference in the data between the two groups,and it was comparable.The comparison of P<0.05?P₁=0.000,P₂=0.000?before and after treatment in the two groups was significantly improved.After treatment,P=0.014 was compared,and the difference was compared with P=0.032 before and after treatment,and the test group was better than the control group.Conclusion:Liqi Huoxue Fang can obviously alleviate the clinical symptoms of chronic pelvic pain syndrome?qi stagnation and blood stasis syndrome?,especially the symptoms of pain,and have a good clinical effect.The main points of the theory of collateral disease include"long disease entering the collaterals"and"long pain entering the collaterals",which are consistent with the pathogenesis of this disease and have guiding significance for the treatment of this disease.